These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12718746)

  • 1. Systemic lupus erythematosus and the type I interferon system.
    Rönnblom L; Alm GV
    Arthritis Res Ther; 2003; 5(2):68-75. PubMed ID: 12718746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural interferon-alpha producing cells in systemic lupus erythematosus.
    Rönnblom L; Alm GV
    Hum Immunol; 2002 Dec; 63(12):1181-93. PubMed ID: 12480262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity.
    Rönnblom L; Eloranta ML; Alm GV
    Autoimmunity; 2003 Dec; 36(8):463-72. PubMed ID: 14984023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.
    Båve U; Magnusson M; Eloranta ML; Perers A; Alm GV; Rönnblom L
    J Immunol; 2003 Sep; 171(6):3296-302. PubMed ID: 12960360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
    Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
    Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An etiopathogenic role for the type I IFN system in SLE.
    Rönnblom L; Alm GV
    Trends Immunol; 2001 Aug; 22(8):427-31. PubMed ID: 11473831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus IgA1 autoantibodies synergize with IgG to enhance plasmacytoid dendritic cell responses to RNA-containing immune complexes.
    Waterman HR; Dufort MJ; Posso SE; Ni M; Li LZ; Zhu C; Raj P; Smith KD; Buckner JH; Hamerman JA
    Sci Transl Med; 2024 Jul; 16(754):eadl3848. PubMed ID: 38959329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type I interferon system in the etiopathogenesis of autoimmune diseases.
    Rönnblom L
    Ups J Med Sci; 2011 Nov; 116(4):227-37. PubMed ID: 22066971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Sacre K; Criswell LA; McCune JM
    Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
    Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
    J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
    Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
    Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.